Study Finds Psoriasis Risk Reduction with Greater Intake of Riboflavin

This analysis suggests intake of riboflavin, also known as vitamin B2, shows an association with patients’ risk of developing psoriasis.

Read the full article here

Related Articles

Digestive Disease Week

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…